Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

A Lupi; Ep Navarese; M Lazzero; M Sansa; S De Servi; A Serra; As Bongo; Antonino Maria Tommaso Buffon

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

A Lupi, Ep Navarese, M Lazzero, M Sansa, S De Servi, A Serra, As Bongo, Antonino Maria Tommaso Buffon

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease.

Lingua originale	English
pagine (da-a)	280-289
Numero di pagine	10
Rivista	Circulation Journal
Volume	75
Stato di pubblicazione	Pubblicato - 2011

Keywords

Aged
Aged, 80 and over
Angioplasty
Bias (Epidemiology)
Clinical Trials as Topic
Coronary Artery Bypass
Coronary Disease
Coronary Restenosis
Diabetic Angiopathies
Drug-Eluting Stents
Female
Follow-Up Studies
Graft Occlusion, Vascular
Humans
Male
Middle Aged
Myocardial Infarction
Odds Ratio
Paclitaxel
Postoperative Complications
Randomized Controlled Trials as Topic
Regression Analysis
Saphenous Vein
Sirolimus
Stents
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{aa4e482db60e443ca5ee1fa2ad1b0c7a,

title = "Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients",

abstract = "Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease.",

keywords = "Aged, Aged, 80 and over, Angioplasty, Bias (Epidemiology), Clinical Trials as Topic, Coronary Artery Bypass, Coronary Disease, Coronary Restenosis, Diabetic Angiopathies, Drug-Eluting Stents, Female, Follow-Up Studies, Graft Occlusion, Vascular, Humans, Male, Middle Aged, Myocardial Infarction, Odds Ratio, Paclitaxel, Postoperative Complications, Randomized Controlled Trials as Topic, Regression Analysis, Saphenous Vein, Sirolimus, Stents, Treatment Outcome, Aged, Aged, 80 and over, Angioplasty, Bias (Epidemiology), Clinical Trials as Topic, Coronary Artery Bypass, Coronary Disease, Coronary Restenosis, Diabetic Angiopathies, Drug-Eluting Stents, Female, Follow-Up Studies, Graft Occlusion, Vascular, Humans, Male, Middle Aged, Myocardial Infarction, Odds Ratio, Paclitaxel, Postoperative Complications, Randomized Controlled Trials as Topic, Regression Analysis, Saphenous Vein, Sirolimus, Stents, Treatment Outcome",

author = "A Lupi and Ep Navarese and M Lazzero and M Sansa and {De Servi}, S and A Serra and As Bongo and Buffon, {Antonino Maria Tommaso}",

year = "2011",

language = "English",

volume = "75",

pages = "280--289",

journal = "Circulation Journal",

issn = "1347-4820",

publisher = "Japanese Circulation Society",

}

TY - JOUR

T1 - Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

AU - Lupi, A

AU - Navarese, Ep

AU - Lazzero, M

AU - Sansa, M

AU - De Servi, S

AU - Serra, A

AU - Bongo, As

AU - Buffon, Antonino Maria Tommaso

PY - 2011

Y1 - 2011

N2 - Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease.

AB - Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease.

KW - Aged

KW - Aged, 80 and over

KW - Angioplasty

KW - Bias (Epidemiology)

KW - Clinical Trials as Topic

KW - Coronary Artery Bypass

KW - Coronary Disease

KW - Coronary Restenosis

KW - Diabetic Angiopathies

KW - Drug-Eluting Stents

KW - Female

KW - Follow-Up Studies

KW - Graft Occlusion, Vascular

KW - Humans

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Odds Ratio

KW - Paclitaxel

KW - Postoperative Complications

KW - Randomized Controlled Trials as Topic

KW - Regression Analysis

KW - Saphenous Vein

KW - Sirolimus

KW - Stents

KW - Treatment Outcome

KW - Aged

KW - Aged, 80 and over

KW - Angioplasty

KW - Bias (Epidemiology)

KW - Clinical Trials as Topic

KW - Coronary Artery Bypass

KW - Coronary Disease

KW - Coronary Restenosis

KW - Diabetic Angiopathies

KW - Drug-Eluting Stents

KW - Female

KW - Follow-Up Studies

KW - Graft Occlusion, Vascular

KW - Humans

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Odds Ratio

KW - Paclitaxel

KW - Postoperative Complications

KW - Randomized Controlled Trials as Topic

KW - Regression Analysis

KW - Saphenous Vein

KW - Sirolimus

KW - Stents

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/57499

M3 - Article

SN - 1347-4820

VL - 75

SP - 280

EP - 289

JO - Circulation Journal

JF - Circulation Journal

ER -

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

Abstract

Keywords

OSS delle Nazioni Unite

Altri file e collegamenti

Fingerprint

Cita questo